Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions-Reference-Cited by-同舟云学术

Identification of SEC62 as a potential marker for 3q amplification and cellular migration in dysplastic cervical lesions

Published:2016-08-23 Issue:1 Volume:16 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Linxweiler Maximilian,Bochen Florian,Schick Bernhard,Wemmert Silke,Al Kadah Basel,Greiner Markus,Hasenfus Andrea,Bohle Rainer-Maria,Juhasz-Böss Ingolf,Solomayer Erich-Franz,Takacs Zoltan Ferenc

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-016-2739-6.pdf

Reference49 articles.

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.

2. Elit LM, Hirte H. Management of advanced or recurrent cervical cancer: chemotherapy and beyond. Expert Rev Anticancer Ther. 2014;14:319–32.

3. Heselmeyer K, Macville M, Schrock E, Blegen H, Hellstrom AC, Shah K, et al. Advanced-stage cervical carcinomas are defined by a recurrent pattern of chromosomal aberrations revealing high genetic instability and a consistent gain of chromosome arm 3q. Gene Chromosomes Cancer. 1997;19:233–40.

4. Allen DG, White DJ, Hutchins AM, Scurry JP, Tabrizi SN, Garland SM, et al. Progressive genetic aberrations detected by comparative genomic hybridization in squamous cell cervical cancer. Br J Cancer. 2000;83:1659–63.

5. Sugita M, Tanaka N, Davidson S, Sekiya S, Varella-Garcia M, West J, et al. Molecular definition of a small amplification domain within 3q26 in tumors of cervix, ovary, and lung. Cancer Genet Cytogenet. 2000;117:9–18.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Selective autophagy in cancer: mechanisms, therapeutic implications, and future perspectives;Molecular Cancer;2024-01-24

2. Dual Sec62/Ki67 immunocytochemistry of liquid‐based cytological preparations represents a highly valid biomarker for non‐invasive detection of head and neck squamous cell carcinomas;Cytopathology;2023-10-03

3. The 3q Oncogene SEC62 Predicts Response to Neoadjuvant Chemotherapy and Regulates Tumor Cell Migration in Triple Negative Breast Cancer;International Journal of Molecular Sciences;2023-05-31

4. Effect of the 3q26-coding oncogene SEC62 as a potential prognostic marker in patients with ovarian neoplasia;Frontiers in Physiology;2023-01-04

5. Co-chaperones of the Human Endoplasmic Reticulum: An Update;Subcellular Biochemistry;2022-12-16